Revisiting platinum-resistant ovarian cancer: Advances in therapy, molecular biomarkers, and clinical outcomes

Affiliations

¹ Cancer Biomarkers Working Group, Oujda, Morocco. Electronic address: k.elbairi@ump.ac.ma.
² Department of Pathology, College of Medicine, University of South Alabama, Mobile, AL, 36617, United States; Cancer Biology Program, Mitchell Cancer Institute, University of South Alabama, Mobile, AL, 36604, United States; Department of Biochemistry and Molecular Biology, College of Medicine, University of South Alabama, Mobile, AL, 36688, United States.
³ Research Institute of McGill University Health Center (RI-MUHC), Montréal, QC, Canada.

Editorial

Khalid El Bairi et al. Semin Cancer Biol. 2021 Dec.

. 2021 Dec:77:1-2.

doi: 10.1016/j.semcancer.2021.09.002. Epub 2021 Sep 4.

¹ Cancer Biomarkers Working Group, Oujda, Morocco. Electronic address: k.elbairi@ump.ac.ma.
² Department of Pathology, College of Medicine, University of South Alabama, Mobile, AL, 36617, United States; Cancer Biology Program, Mitchell Cancer Institute, University of South Alabama, Mobile, AL, 36604, United States; Department of Biochemistry and Molecular Biology, College of Medicine, University of South Alabama, Mobile, AL, 36688, United States.
³ Research Institute of McGill University Health Center (RI-MUHC), Montréal, QC, Canada.

No abstract available

Publication types